What led Pharmaniaga to be classified as PN17?

Question

Accepted Answer

Pharmaniaga's PN17 Classification Triggered by RM552.3 Million Provision for Slow-Moving Covid-19 Vaccine Inventories

Pharmaniaga Bhd was classified as Practice Note 17 (PN17) in February 2023 primarily due to a significant provision of RM552.3 million. This provision was made for "slow-moving inventories" specifically related to Covid-19 vaccines. The substantial write-down of these vaccine stocks impacted the company's financial health, leading to its classification under the PN17 status by Bursa Malaysia.
Significant Provision for Vaccine Stock

The core reason for Pharmaniaga's PN17 classification was the substantial financial provision it had to make. This provision, amounting to RM552.3 million, was specifically earmarked for Covid-19 vaccine inventories that were no longer considered fast-moving. This indicates a considerable overstocking or a sharp decline in demand for these particular vaccine products.
Impact on Financial Health

The need to account for RM552.3 million in slow-moving vaccine inventories placed significant pressure on Pharmaniaga's financial statements. PN17 status is typically triggered when a listed company's financial condition deteriorates, often due to accumulated losses, inadequate equity, or default on financial obligations. The large provision directly affected the company's profitability and equity base, meeting the criteria for this classification.
Timing of Classification

Pharmaniaga officially entered PN17 status in February 2023. This classification followed the company's internal assessments and external financial reporting that revealed the extent of the issue with its Covid-19 vaccine inventory. The announcement of this status marked a critical juncture for the pharmaceutical company, requiring it to undertake a regularisation plan.

Reading history

Hide →

This history is cleared when the page is closed.

What led Pharmaniaga to be classified as PN17?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends